COVID-19: Information on ASPIRA LABS Operations

Click to Learn More

At ASPIRA Women's Health we strive to globally transform women's health, starting with ovarian cancer.

We are committed to solving women's health issues for all ethnicities, stages, and ages. Our data-driven approach delivers solutions that help women take control of their gynecologic health and empowers providers to deliver optimal care. We are using our 10+ years of experience in ovarian cancer risk assessment to develop a cutting-edge portfolio of pelvic mass products.

Learn About Our Research

Our Products


  • Relentless pursuit of products to improve ovarian cancer detection and care. Learn about why OVA1plus is the best way to assess risk prior to surgery.

    Learn More
  • Hereditary breast and ovarian cancer detection and carrier screening. Learn about your inherited risk through genetic testing.

    Learn More

Testimonials


  • OVA1 is using five different biomarkers compared to other tests, and is much more sensitive especially for detection of early stage disease.

    - Kathy Anderson MD, FACOG, JD, ABAARM
  • OVA1 is great in that it can help to avoid second procedures on patients and second operations which can be associated with higher morbidity.

    - Jonathan Black MD, MPH
  • OVA1®plus has added to our armamentarium as physicians by decreasing the false positive rate up to 50%

    - Howard C. Mandel MD, FACOG

Latest News & Events

View More

Careers At Aspira Women's Health

At ASPIRA Women's health our mission is to globally transform women's health, starting with ovarian cancer.


We are always looking for talented, driven individuals to join our team of innovators. We are a small company with some very big ideas.

Are you ready to help us inspire change in women's health? Then we want to hear from you!